Megean A Eggert, PLMFT | |
860 Lynn St, Lebanon, MO 65536-3810 | |
(844) 853-8937 | |
Not Available |
Full Name | Megean A Eggert |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 860 Lynn St, Lebanon, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477339588 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 2022050170 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Megean A Eggert, PLMFT 1800 Community, Clinton, MO 64735-8804 Ph: (660) 885-8131 | Megean A Eggert, PLMFT 860 Lynn St, Lebanon, MO 65536-3810 Ph: (844) 853-8937 |
News Archive
For years, Coloradans have lived with uncertainty about their health insurance: lifetime caps, recisions, coverage for life-saving screenings. New provisions that begin Thursday, the six-month anniversary of the signing of the Affordable Care Act, address some of the biggest concerns consumers had about the failing health system (Dede de Percin, 9/22).
A study presented at the ANESTHESIOLOGY 2012 annual meeting found that during the years 2000-2009, eye injuries during robotic-assisted radical prostatectomy (RARP) increased nearly 10-fold, from a .07 percent incidence rate to .42 percent.
Acute lymphatic leukemia is the most common form of blood cancer in children. Even though chemotherapy is improving, the cancer often returns. Johan Jansson's research at Kalmar University in Sweden shows that cancer cells that have been exposed to chemotherapy and survived are less vulnerable to chemotherapy, and more aggressive as well. But this research also yielded discoveries that should be able to enhance our treatment of the disease.
BioDelivery Sciences International, Inc. announced the issuance of a patent extending the exclusivity of the BioErodible MucoAdhesive drug delivery technology in Canada from 2017 to 2027. The patent was been reviewed by the Office of Patented Medicines for listing in the Canadian Patent Register and was found eligible for listing.
Université de Montréal's Laboratory of Biosensors & Nanomachines, in partnership with Montreal company Nanogenecs Diagnostics, has just been awarded a 700 000$ NSERC 'Idea to Innovation' grant to develop a home blood-testing device for people with chronic illnesses.
› Verified 6 days ago